We intend to achieve our objectives through our team of highly skilled, accomplished professionals who share a determination to meaningfully improve the diagnosis and treatment of patients with prostate cancer. If you thrive in an entrepreneurial, stimulating environment where initiative and individual contributions are valued and rewarded, we would like to hear from you.
Note to Recruiters
Third party recruiters and search agencies are important to staffing efforts at Progenics, and we value our partnerships. All staffing vendors must have a written agreement in place in order to receive compensation for any candidate referrals. Progenics does not accept unsolicited resumes from third party agencies for open positions.
If you have questions about our recruiting policies or practices, please contact the Progenics HR team. Progenics is an Equal Opportunity/Affirmative Action Employer M/F/D/V.
The Clinical Data Manager (CDM) will be responsible for all data management activities from study start up to database lock to ensure timely quality deliveries. The CDM will work on studies independently or will manage CROs & interact with the clinical team as well as outside vendors.
Progenics is seeking a temporary Application Administrator and Validation Specialist for a 6-month assignment.
Progenics is seeking a Director/Senior Director, Regulatory.
We are seeking a temporary senior manager to provide scientific and technical support in the area of analytical method assessment, development, transfer, validation, and troubleshooting methods. This position is a 6-month temporary assignment.
The Senior Director will be responsible for process development of Progenics’ novel radiopharmaceutical therapeutic and imaging products. The individual will also responsible for manufacture of radiopharmaceuticals and active pharmaceutical ingredients at external Contract Manufacturing Organizations (CMOs). This is a key leadership position that will interface with various functions at Progenics as well as Progenics’ partners to ensure timely and cost-effective development and manufacturing of radiopharmaceutical drugs for clinical supply and commercial launch.